10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2020 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 9, 2021) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Revenues: | |||
| Product sales | $ 25,424 | 23,362 | 23,747 |
| Total revenues | 25,424 | 23,362 | 23,747 |
| Operating expenses: | |||
| Cost of sales | 6,159 | 4,356 | 4,101 |
| Research and development | 4,207 | 4,116 | 3,737 |
| Selling, general and administrative | 5,730 | 5,150 | 5,332 |
| Other | 189 | 66 | 314 |
| Total operating expenses | 16,285 | 13,688 | 13,484 |
| Operating income | 9,139 | 9,674 | 10,263 |
| Interest expense, net | 1,262 | 1,289 | 1,392 |
| Interest and other income, net | 256 | 753 | 674 |
| Income before income taxes | 8,133 | 9,138 | 9,545 |
| Provision for income taxes | 869 | 1,296 | 1,151 |
| Net income | 7,264 | 7,842 | 8,394 |
| Earnings per share: | |||
| Basic (in usd per share) | 12.40 | 12.96 | 12.70 |
| Diluted (in usd per share) | 12.31 | 12.88 | 12.62 |
| Shares used in the calculation of earnings per share: | |||
| Basic (in shares) | 586 | 605 | 661 |
| Diluted (in shares) | 590 | 609 | 665 |
| Product and Service | |||
| Product sales | |||
| Product sales | 24,240 | 22,204 | 22,533 |
| Other | |||
| Product sales | 1,184 | 1,158 | 1,214 |
| Other revenues | 1,184 | 1,158 | 1,214 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2020 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 9, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Net income | $ 7,264 | 7,842 | 8,394 |
| Other comprehensive (loss) income, net of reclassification adjustments and taxes: | |||
| Gains (losses) on foreign currency translation | 9 | (48) | (141) |
| (Losses) gains on cash flow hedges | (438) | (66) | 247 |
| (Losses) gains on available-for-sale securities | (21) | 360 | (185) |
| Other losses | (7) | (5) | (2) |
| Other comprehensive (loss) income, net of taxes | (457) | 241 | (81) |
| Comprehensive income | 6,807 | 8,083 | 8,313 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2020 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 9, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Cash flows from operating activities: | |||
| Net income | $ 7,264 | 7,842 | 8,394 |
| Depreciation, amortization and other | 3,601 | 2,206 | 1,946 |
| Stock-based compensation expense | 330 | 308 | 311 |
| Deferred income taxes | (287) | (289) | (363) |
| Other items, net | (195) | (186) | 386 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (427) | (504) | (378) |
| Inventories | (215) | (66) | (3) |
| Other assets | 129 | 10 | 35 |
| Accounts payable | 45 | 164 | (143) |
| Accrued income taxes, net | (249) | (585) | (361) |
| Long-term tax liabilities | (482) | (146) | 258 |
| Other liabilities | 983 | 396 | 1,214 |
| Net cash provided by operating activities | 10,497 | 9,150 | 11,296 |
| Cash flows from investing activities: | |||
| Purchases of marketable securities | (8,477) | (9,394) | (18,741) |
| Proceeds from sales of marketable securities | 2,597 | 8,842 | 28,356 |
| Proceeds from maturities of marketable securities | 4,381 | 20,548 | 5,412 |
| Purchases of property, plant and equipment | (608) | (618) | (738) |
| Cash paid for acquisitions, net of cash acquired | 0 | (13,617) | 195 |
| Payments to Acquire Equity Method Investments | (3,219) | (24) | (40) |
| Other | (75) | (28) | (105) |
| Net cash (used in) provided by investing activities | (5,401) | 5,709 | 14,339 |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 8,914 | 0 | 0 |
| Repayment of debt | (6,450) | (4,514) | (1,121) |
| Repurchases of common stock | (3,486) | (7,702) | (17,794) |
| Dividends paid | (3,755) | (3,509) | (3,507) |
| Other | (90) | (42) | (68) |
| Net cash used in financing activities | (4,867) | (15,767) | (22,490) |
| Increase (decrease) in cash and cash equivalents | 229 | (908) | 3,145 |
| Cash and cash equivalents at beginning of year | 6,037 | 6,945 | |
| Cash and cash equivalents at end of year | 6,266 | 6,037 | 6,945 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2020 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2020 10-K (Filed: Feb 9, 2021) | ||
| (In Millions, except shares in Thousands) | ||
| As of | As of | |
| Dec 31, 2020 | Dec 31, 2019 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 6,266 | 6,037 |
| Marketable securities | 4,381 | 2,874 |
| Trade receivables, net | 4,525 | 4,057 |
| Inventories | 3,893 | 3,584 |
| Other current assets | 2,079 | 1,888 |
| Total current assets | 21,144 | 18,440 |
| Property, plant and equipment, net | 4,889 | 4,928 |
| Intangible assets, net | 16,587 | 19,413 |
| Goodwill | 14,689 | 14,703 |
| Other assets | 5,639 | 2,223 |
| Total assets | 62,948 | 59,707 |
| LIABILITIES AND STOCKHOLDERS EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 1,421 | 1,371 |
| Accrued liabilities | 10,141 | 8,511 |
| Current portion of long-term debt | 91 | 2,953 |
| Total current liabilities | 11,653 | 12,835 |
| Long-term debt | 32,895 | 26,950 |
| Long-term tax liabilities | 6,968 | 8,037 |
| Other noncurrent liabilities | 2,023 | 2,212 |
| Contingencies and commitments | ||
| Common Stock, Shares Authorized | 2,750,000 | 2,750,000 |
| Common Stock, Shares, Outstanding | 578,300 | 591,400 |
| Common Stock, Par or Stated Value Per Share | 0.0001 | 0.0001 |
| Stockholders equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value per share; 2,750.0 shares authorized; outstanding 578.3 shares in 2020 and 591.4 shares in 2019 | 31,802 | 31,531 |
| Accumulated deficit | (21,408) | (21,330) |
| Accumulated other comprehensive loss | (985) | (528) |
| Total stockholders equity | 9,409 | 9,673 |
| Total liabilities and stockholders equity | 62,948 | 59,707 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |